Pathophysiology and management of pulmonary infections in cystic fibrosis
RL Gibson, JL Burns, BW Ramsey - American journal of respiratory …, 2003 - atsjournals.org
This comprehensive State of the Art review summarizes the current published knowledge
base regarding the pathophysiology and microbiology of pulmonary disease in cystic …
base regarding the pathophysiology and microbiology of pulmonary disease in cystic …
Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screening
JL Bobadilla, M Macek Jr, JP Fine… - Human mutation, 2002 - Wiley Online Library
Although there have been numerous reports from around the world of mutations in the gene
of chromosome 7 known as CFTR (cystic fibrosis transmembrane conductance regulator) …
of chromosome 7 known as CFTR (cystic fibrosis transmembrane conductance regulator) …
A genetic profile of contemporary Jewish populations
H Ostrer - Nature Reviews Genetics, 2001 - nature.com
The Jews are an ancient people with a history spanning several millennia. Genetic studies
over the past 50 years have shed light on Jewish origins, the relatedness of Jewish …
over the past 50 years have shed light on Jewish origins, the relatedness of Jewish …
The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.
N Rave-Harel, E Kerem, M Nissim-Rafinia… - American journal of …, 1997 - ncbi.nlm.nih.gov
The splicing variant, 5T allele, in intron 8 of the cystic fibrosis transmembrane conductance
regulator (CFTR) gene was shown to be associated with partial penetrance of the clinical …
regulator (CFTR) gene was shown to be associated with partial penetrance of the clinical …
Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection
N Risch, H Tang, H Katzenstein, J Ekstein - The American Journal of …, 2003 - cell.com
The presence of four lysosomal storage diseases (LSDs) at increased frequency in the
Ashkenazi Jewish population has suggested to many the operation of natural selection …
Ashkenazi Jewish population has suggested to many the operation of natural selection …
Clinical and genetic risk factors for cystic fibrosis-related liver disease
M Wilschanski, J Rivlin, S Cohen, A Augarten… - …, 1999 - publications.aap.org
Objective. The aim of this study was to define the role of possible risk factors for the
development of cystic fibrosis (CF)-related liver disease and to analyze the association …
development of cystic fibrosis (CF)-related liver disease and to analyze the association …
[HTML][HTML] Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population
GE Palomaki, SC Fitzsimmons, JE Haddow - Genetics in Medicine, 2004 - Elsevier
Purpose: To estimate CFTR mutation frequencies, clinical sensitivities (proportions of carrier
couples or affected fetuses detected), and birth prevalence estimates for broad racial/ethnic …
couples or affected fetuses detected), and birth prevalence estimates for broad racial/ethnic …
The molecular basis for disease variability in cystic fibrosis
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR) gene. The disease is characterized …
fibrosis transmembrane conductance regulator (CFTR) gene. The disease is characterized …
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families
METHODS Records of all patients seen by the Clinical Genetics Service at Memorial Sloan-
Kettering Cancer Center (MSKCC) from 1.6. 95 to 30.6. 01, who identified themselves as …
Kettering Cancer Center (MSKCC) from 1.6. 95 to 30.6. 01, who identified themselves as …
Genetic testing in Israel: an overview
G Rosner, S Rosner… - Annual review of genomics …, 2009 - annualreviews.org
In Israel, genetic screening and testing are widespread and are on the rise. The socialized
medical system, the governmental National Program for the Detection and Prevention of …
medical system, the governmental National Program for the Detection and Prevention of …